You'd have to think that going to Lang was, and importantly remains, Plan B.
It hard not to compare this CR with others in the biotech space (eg ADO) and respect the business acumen of our leadership.
Ann: Neuren secures funding for key activities for Rett syndrome, page-17
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.81 |
Change
0.200(1.47%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $2.894M | 209.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 142 | $13.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.82 | 641 | 13 |
View Market Depth
| Last trade - 15.36pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |